Clinical outcome and bromodeoxyuridine derived proliferation indices in 100 colonic and rectal carcinomas
Clinical outcome and bromodeoxyuridine derived proliferation indices in 100 colonic and rectal carcinomas
Aim: In vivo labelling of human colonic and rectal tumours with bromodeoxyuridine (BrdUrd) and analysis by flow cytometry (FCM) allows the labelling index (LI), S phase duration (Ts) and the potential doubling time (Tpot) of the tumour to be estimated in vivo.
Methods: The data for a series of 100 tumour specimens from 97 patients with colonic and rectal carcinoma was reported in 1991, and correlated with Dukes' classification and histological differentiation.
Results: This study reports the eventual outcome of the 97 patients after 12 years. There were no significant associations between proliferation data of the index tumours and patient outcome. No adverse events were identified which could be attributed to the use of the halogenated pyrimidine label in vivo.
Conclusion: Dynamic cell proliferation indices provide detailed information on the cell kinetics of colorectal tumours but these do not correlate with clinical prognostic markers or outcome.
colonic cancer, rectal cancer, bromodeoxyuridine, cell proliferation, outcome
516-519
Cutress, R.I.
68ae4f86-e8cf-411f-a335-cdba51797406
Mullee, M.A.
fd3f91c3-5e95-4f56-8d73-260824eeb362
Rew, D.A.
36dcc3ad-2379-4b61-a468-5c623d796887
2002
Cutress, R.I.
68ae4f86-e8cf-411f-a335-cdba51797406
Mullee, M.A.
fd3f91c3-5e95-4f56-8d73-260824eeb362
Rew, D.A.
36dcc3ad-2379-4b61-a468-5c623d796887
Cutress, R.I., Mullee, M.A. and Rew, D.A.
(2002)
Clinical outcome and bromodeoxyuridine derived proliferation indices in 100 colonic and rectal carcinomas.
European Journal of Surgical Oncology, 28 (5), .
(doi:10.1053/ejso.2002.1281).
(PMID:12217304)
Abstract
Aim: In vivo labelling of human colonic and rectal tumours with bromodeoxyuridine (BrdUrd) and analysis by flow cytometry (FCM) allows the labelling index (LI), S phase duration (Ts) and the potential doubling time (Tpot) of the tumour to be estimated in vivo.
Methods: The data for a series of 100 tumour specimens from 97 patients with colonic and rectal carcinoma was reported in 1991, and correlated with Dukes' classification and histological differentiation.
Results: This study reports the eventual outcome of the 97 patients after 12 years. There were no significant associations between proliferation data of the index tumours and patient outcome. No adverse events were identified which could be attributed to the use of the halogenated pyrimidine label in vivo.
Conclusion: Dynamic cell proliferation indices provide detailed information on the cell kinetics of colorectal tumours but these do not correlate with clinical prognostic markers or outcome.
This record has no associated files available for download.
More information
Published date: 2002
Keywords:
colonic cancer, rectal cancer, bromodeoxyuridine, cell proliferation, outcome
Identifiers
Local EPrints ID: 24316
URI: http://eprints.soton.ac.uk/id/eprint/24316
ISSN: 0748-7983
PURE UUID: e1d96625-d67c-45c8-9f98-23adeb40fe9b
Catalogue record
Date deposited: 29 Mar 2006
Last modified: 16 Mar 2024 04:40
Export record
Altmetrics
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
